T. Rowe Price Innovation Leaders ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: --
資產淨值: 27.56
成立日期: 28/01/2026
 
分析
市值分佈:
94.78%
大市值
2.62%
中市值
0.90%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:08) 總持有投資項目: 250  
0%
 
100%
     10大 (34.06%)
代號 名稱 佔比% ▼ 持有日期
KRYSKrystal Biotech0.1231/10/2026
THLEFTHALES0.1231/10/2026
MSCIMSCI Inc.0.1231/10/2026
RXRXRecursion Pharmaceuticals0.1231/10/2026
CGONCG Oncology0.1230/09/2026
RLAYRelay Therapeutics0.1231/10/2026
ADTTFAdvantest Corp.0.1131/10/2026
MDBMongoDB0.1131/10/2026
ELVNEnliven Therapeutics0.1130/09/2026
IDYAIDEAYA Biosciences0.1131/10/2026
DNTHDianthus Therapeutics0.1030/09/2026
DFTXDefinium Therapeutics Inc0.1031/10/2026
ASNDAscendis Pharma A/S0.1030/09/2026
MDGLMadrigal Pharmaceuticals0.1031/10/2026
PVLAPalvella Therapeutics Inc0.1031/10/2026
APGAPi Group Corporation0.1031/10/2026
NAMSNewAmsterdam Pharma Company NV0.1031/10/2026
COINCoinbase Global0.0931/10/2026
CLYMClimb Bio Inc0.0931/10/2026
PCVXVaxcyte0.0931/10/2026
  1    2    3    4    5    6    7    8    9   10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.